(Q28295656)
Statements
Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up (English)
0 references
28
0 references
10
0 references
1387-94
0 references